chr5-138286570-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The ENST00000323760.11(CDC25C):c.1087G>A(p.Val363Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000107 in 1,613,800 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
ENST00000323760.11 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CDC25C | NM_001790.5 | c.1087G>A | p.Val363Ile | missense_variant | 12/14 | ENST00000323760.11 | NP_001781.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CDC25C | ENST00000323760.11 | c.1087G>A | p.Val363Ile | missense_variant | 12/14 | 1 | NM_001790.5 | ENSP00000321656 | P2 |
Frequencies
GnomAD3 genomes AF: 0.0000657 AC: 10AN: 152138Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000159 AC: 40AN: 251334Hom.: 0 AF XY: 0.000169 AC XY: 23AN XY: 135840
GnomAD4 exome AF: 0.000111 AC: 162AN: 1461544Hom.: 0 Cov.: 31 AF XY: 0.000125 AC XY: 91AN XY: 727092
GnomAD4 genome AF: 0.0000657 AC: 10AN: 152256Hom.: 0 Cov.: 32 AF XY: 0.0000806 AC XY: 6AN XY: 74430
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 03, 2022 | The c.1087G>A (p.V363I) alteration is located in exon 12 (coding exon 11) of the CDC25C gene. This alteration results from a G to A substitution at nucleotide position 1087, causing the valine (V) at amino acid position 363 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at